Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.08
XRAY's Cash to Debt is ranked lower than
95% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.42 vs. XRAY: 0.08 )
Ranked among companies with meaningful Cash to Debt only.
XRAY' s 10-Year Cash to Debt Range
Min: 0.02  Med: 0.06 Max: 1.01
Current: 0.08
0.02
1.01
Equity to Asset 0.50
XRAY's Equity to Asset is ranked lower than
65% of the 168 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. XRAY: 0.50 )
Ranked among companies with meaningful Equity to Asset only.
XRAY' s 10-Year Equity to Asset Range
Min: 0.34  Med: 0.51 Max: 0.61
Current: 0.5
0.34
0.61
Interest Coverage 9.50
XRAY's Interest Coverage is ranked lower than
76% of the 104 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.79 vs. XRAY: 9.50 )
Ranked among companies with meaningful Interest Coverage only.
XRAY' s 10-Year Interest Coverage Range
Min: 4.1  Med: 10.36 Max: 29.14
Current: 9.5
4.1
29.14
F-Score: 6
Z-Score: 4.21
M-Score: -2.96
WACC vs ROIC
9.99%
9.46%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 15.37
XRAY's Operating margin (%) is ranked higher than
78% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.07 vs. XRAY: 15.37 )
Ranked among companies with meaningful Operating margin (%) only.
XRAY' s 10-Year Operating margin (%) Range
Min: 4.25  Med: 17.37 Max: 18.42
Current: 15.37
4.25
18.42
Net-margin (%) 11.02
XRAY's Net-margin (%) is ranked higher than
73% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.95 vs. XRAY: 11.02 )
Ranked among companies with meaningful Net-margin (%) only.
XRAY' s 10-Year Net-margin (%) Range
Min: 2.65  Med: 10.76 Max: 14.94
Current: 11.02
2.65
14.94
ROE (%) 12.98
XRAY's ROE (%) is ranked higher than
71% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.63 vs. XRAY: 12.98 )
Ranked among companies with meaningful ROE (%) only.
XRAY' s 10-Year ROE (%) Range
Min: 3.38  Med: 17.79 Max: 21.51
Current: 12.98
3.38
21.51
ROA (%) 6.52
XRAY's ROA (%) is ranked higher than
68% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.88 vs. XRAY: 6.52 )
Ranked among companies with meaningful ROA (%) only.
XRAY' s 10-Year ROA (%) Range
Min: 1.74  Med: 9.12 Max: 11.68
Current: 6.52
1.74
11.68
ROC (Joel Greenblatt) (%) 37.34
XRAY's ROC (Joel Greenblatt) (%) is ranked higher than
79% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. XRAY: 37.34 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
XRAY' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 14.79  Med: 49.44 Max: 88.37
Current: 37.34
14.79
88.37
Revenue Growth (3Y)(%) 4.70
XRAY's Revenue Growth (3Y)(%) is ranked lower than
52% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. XRAY: 4.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
XRAY' s 10-Year Revenue Growth (3Y)(%) Range
Min: 3.8  Med: 9.00 Max: 21.5
Current: 4.7
3.8
21.5
EBITDA Growth (3Y)(%) 14.50
XRAY's EBITDA Growth (3Y)(%) is ranked higher than
65% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.90 vs. XRAY: 14.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
XRAY' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -22.4  Med: 8.30 Max: 50.5
Current: 14.5
-22.4
50.5
EPS Growth (3Y)(%) 9.60
XRAY's EPS Growth (3Y)(%) is ranked higher than
56% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. XRAY: 9.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
XRAY' s 10-Year EPS Growth (3Y)(%) Range
Min: -32.7  Med: 9.50 Max: 88.3
Current: 9.6
-32.7
88.3
» XRAY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

XRAY Guru Trades in Q2 2014

Joel Greenblatt 72,218 sh (New)
Mario Gabelli 189,740 sh (unchged)
Vanguard Health Care Fund 2,826,100 sh (unchged)
Chuck Royce 232,588 sh (-7.82%)
Paul Tudor Jones 9,906 sh (-23.56%)
Robert Olstein 70,000 sh (-38.05%)
Jim Simons 247,658 sh (-66.04%)
» More
Q3 2014

XRAY Guru Trades in Q3 2014

First Eagle Investment 114,805 sh (New)
Joel Greenblatt 287,229 sh (+297.72%)
Jim Simons 425,158 sh (+71.67%)
Chuck Royce 239,988 sh (+3.18%)
Paul Tudor Jones 10,056 sh (+1.51%)
Vanguard Health Care Fund 2,826,100 sh (unchged)
Robert Olstein 70,000 sh (unchged)
Mario Gabelli 187,280 sh (-1.30%)
» More
Q4 2014

XRAY Guru Trades in Q4 2014

Joel Greenblatt 939,130 sh (+226.96%)
First Eagle Investment 315,056 sh (+174.43%)
Vanguard Health Care Fund 3,258,900 sh (+15.31%)
Chuck Royce 243,128 sh (+1.31%)
Robert Olstein Sold Out
Jim Simons Sold Out
Mario Gabelli 174,840 sh (-6.64%)
Paul Tudor Jones 7,604 sh (-24.38%)
» More
Q1 2015

XRAY Guru Trades in Q1 2015

Jim Simons 302,558 sh (New)
Paul Tudor Jones 23,638 sh (+210.86%)
Joel Greenblatt 1,479,619 sh (+57.55%)
Vanguard Health Care Fund 3,258,900 sh (unchged)
First Eagle Investment Sold Out
Mario Gabelli 168,320 sh (-3.73%)
Chuck Royce 73,600 sh (-69.73%)
» More
» Details

Insider Trades

Latest Guru Trades with XRAY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 23.56
XRAY's P/E(ttm) is ranked higher than
67% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.10 vs. XRAY: 23.56 )
Ranked among companies with meaningful P/E(ttm) only.
XRAY' s 10-Year P/E(ttm) Range
Min: 12.19  Med: 21.10 Max: 116
Current: 23.56
12.19
116
Forward P/E 18.69
XRAY's Forward P/E is ranked higher than
67% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.98 vs. XRAY: 18.69 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 24.00
XRAY's PE(NRI) is ranked higher than
64% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.00 vs. XRAY: 24.00 )
Ranked among companies with meaningful PE(NRI) only.
XRAY' s 10-Year PE(NRI) Range
Min: 12.2  Med: 21.32 Max: 116
Current: 24
12.2
116
P/B 3.30
XRAY's P/B is ranked lower than
54% of the 170 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.89 vs. XRAY: 3.30 )
Ranked among companies with meaningful P/B only.
XRAY' s 10-Year P/B Range
Min: 2.07  Med: 2.82 Max: 4.65
Current: 3.3
2.07
4.65
P/S 2.59
XRAY's P/S is ranked higher than
52% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.70 vs. XRAY: 2.59 )
Ranked among companies with meaningful P/S only.
XRAY' s 10-Year P/S Range
Min: 1.58  Med: 2.39 Max: 3.59
Current: 2.59
1.58
3.59
PFCF 15.91
XRAY's PFCF is ranked higher than
86% of the 81 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.24 vs. XRAY: 15.91 )
Ranked among companies with meaningful PFCF only.
XRAY' s 10-Year PFCF Range
Min: 12.39  Med: 19.66 Max: 28.2
Current: 15.91
12.39
28.2
POCF 13.15
XRAY's POCF is ranked higher than
72% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.89 vs. XRAY: 13.15 )
Ranked among companies with meaningful POCF only.
XRAY' s 10-Year POCF Range
Min: 10.41  Med: 15.31 Max: 21.82
Current: 13.15
10.41
21.82
EV-to-EBIT 19.31
XRAY's EV-to-EBIT is ranked higher than
57% of the 116 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.04 vs. XRAY: 19.31 )
Ranked among companies with meaningful EV-to-EBIT only.
XRAY' s 10-Year EV-to-EBIT Range
Min: 9.8  Med: 18.30 Max: 71.7
Current: 19.31
9.8
71.7
PEG 3.43
XRAY's PEG is ranked lower than
58% of the 64 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.97 vs. XRAY: 3.43 )
Ranked among companies with meaningful PEG only.
XRAY' s 10-Year PEG Range
Min: 0.58  Med: 3.07 Max: 80.69
Current: 3.43
0.58
80.69
Shiller P/E 24.84
XRAY's Shiller P/E is ranked higher than
65% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.41 vs. XRAY: 24.84 )
Ranked among companies with meaningful Shiller P/E only.
XRAY' s 10-Year Shiller P/E Range
Min: 15.81  Med: 23.67 Max: 37.62
Current: 24.84
15.81
37.62
Current Ratio 1.81
XRAY's Current Ratio is ranked lower than
66% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.56 vs. XRAY: 1.81 )
Ranked among companies with meaningful Current Ratio only.
XRAY' s 10-Year Current Ratio Range
Min: 1.2  Med: 1.78 Max: 3.9
Current: 1.81
1.2
3.9
Quick Ratio 1.24
XRAY's Quick Ratio is ranked lower than
64% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.68 vs. XRAY: 1.24 )
Ranked among companies with meaningful Quick Ratio only.
XRAY' s 10-Year Quick Ratio Range
Min: 0.76  Med: 1.06 Max: 2.98
Current: 1.24
0.76
2.98
Days Inventory 121.06
XRAY's Days Inventory is ranked higher than
51% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 125.77 vs. XRAY: 121.06 )
Ranked among companies with meaningful Days Inventory only.
XRAY' s 10-Year Days Inventory Range
Min: 90.27  Med: 101.72 Max: 150.84
Current: 121.06
90.27
150.84
Days Sales Outstanding 52.51
XRAY's Days Sales Outstanding is ranked higher than
68% of the 153 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.15 vs. XRAY: 52.51 )
Ranked among companies with meaningful Days Sales Outstanding only.
XRAY' s 10-Year Days Sales Outstanding Range
Min: 51.46  Med: 56.43 Max: 61.92
Current: 52.51
51.46
61.92

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.54
XRAY's Dividend Yield is ranked lower than
84% of the 149 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.37 vs. XRAY: 0.54 )
Ranked among companies with meaningful Dividend Yield only.
XRAY' s 10-Year Dividend Yield Range
Min: 0.35  Med: 0.53 Max: 0.85
Current: 0.54
0.35
0.85
Dividend Payout 0.12
XRAY's Dividend Payout is ranked higher than
87% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.34 vs. XRAY: 0.12 )
Ranked among companies with meaningful Dividend Payout only.
XRAY' s 10-Year Dividend Payout Range
Min: 0.05  Med: 0.11 Max: 5.67
Current: 0.12
0.05
5.67
Dividend growth (3y) 8.90
XRAY's Dividend growth (3y) is ranked higher than
50% of the 56 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.90 vs. XRAY: 8.90 )
Ranked among companies with meaningful Dividend growth (3y) only.
XRAY' s 10-Year Dividend growth (3y) Range
Min: 3.2  Med: 9.80 Max: 14.8
Current: 8.9
3.2
14.8
Yield on cost (5-Year) 0.73
XRAY's Yield on cost (5-Year) is ranked lower than
73% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.52 vs. XRAY: 0.73 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
XRAY' s 10-Year Yield on cost (5-Year) Range
Min: 0.48  Med: 0.72 Max: 1.15
Current: 0.73
0.48
1.15
Share Buyback Rate -0.20
XRAY's Share Buyback Rate is ranked higher than
74% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.10 vs. XRAY: -0.20 )
Ranked among companies with meaningful Share Buyback Rate only.
XRAY' s 10-Year Share Buyback Rate Range
Min: 2.2  Med: 0.60 Max: -1.3
Current: -0.2

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.31
XRAY's Price/Projected FCF is ranked higher than
69% of the 91 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.77 vs. XRAY: 1.31 )
Ranked among companies with meaningful Price/Projected FCF only.
XRAY' s 10-Year Price/Projected FCF Range
Min: 0.99  Med: 1.32 Max: 2.39
Current: 1.31
0.99
2.39
Price/DCF (Earnings Based) 1.45
XRAY's Price/DCF (Earnings Based) is ranked higher than
67% of the 18 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.72 vs. XRAY: 1.45 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.09
XRAY's Price/Median PS Value is ranked higher than
57% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.24 vs. XRAY: 1.09 )
Ranked among companies with meaningful Price/Median PS Value only.
XRAY' s 10-Year Price/Median PS Value Range
Min: 0.6  Med: 0.92 Max: 1.44
Current: 1.09
0.6
1.44
Price/Peter Lynch Fair Value 3.01
XRAY's Price/Peter Lynch Fair Value is ranked lower than
76% of the 45 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.96 vs. XRAY: 3.01 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
XRAY' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.65  Med: 1.66 Max: 11.61
Current: 3.01
0.65
11.61
Earnings Yield (Greenblatt) (%) 5.28
XRAY's Earnings Yield (Greenblatt) (%) is ranked higher than
72% of the 177 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. XRAY: 5.28 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
XRAY' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 1.4  Med: 5.50 Max: 10.2
Current: 5.28
1.4
10.2
Forward Rate of Return (Yacktman) (%) 12.36
XRAY's Forward Rate of Return (Yacktman) (%) is ranked higher than
53% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.68 vs. XRAY: 12.36 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
XRAY' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -5.1  Med: 11.10 Max: 33.3
Current: 12.36
-5.1
33.3

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:DY2.Germany,
DENTSPLY International, Inc. was incorporated in 1899 in Delaware. The Company is a designer, developer, manufacturer and marketer of consumable dental products for the professional dental market. The Company also manufactures and markets other consumable medical device products. The Company's main product categories are dental consumable products, dental laboratory products, dental specialty products and consumable medical device products. The Company conducted its business through four operating segments. All of the Company's segments are mainly engaged in the design, manufacture and distribution of dental and medical products in four principal product categories: dental consumable products; dental laboratory products; dental specialty products; and consumable medical device products. Dental consumable products consist of dental sundries and small equipment used in dental offices for the treatment of patients. The Company's dental sundry products in the dental consumable products category include dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners and topical fluoride. Dental laboratory products are used in the preparation of dental appliances by dental laboratories. The Company's products in the dental laboratory products category include dental prosthetics, including artificial teeth, precious metal dental alloys, dental ceramics and crown and bridge materials. Dental specialty products are specialized treatment products used within the dental office and laboratory settings. The Company's products in this category include endodontic (root canal) instruments and materials, implants and related products, bone grafting materials, 3D digital implantology, dental lasers and orthodontic appliances and accessories. Consumable medical device products consist mainly of urological products including catheters, certain surgical products, medical drills and other non-medical products. The Company conducts its business in the United States of America ('U.S.'), as well as in over 120 foreign countries, principally through its foreign subsidiaries. The Company has presence in the European market, particularly in Germany, Sweden, Switzerland, France, Italy and the United Kingdom as well as in Canada. The Company also has market presence in the countries of the Commonwealth of Independent States ('CIS'), Central and South America and the Pacific Rim. The Company's products are subject to regulation by, among other governmental entities, the U.S. Food and Drug Administration.
» More Articles for XRAY

Headlines

Articles On GuruFocus.com
DENTSPLY´s Growth Opportunities Dec 16 2014 
Weekly Insider Sells Highlight: ORCL, ALXN, WAT, XRAY Dec 08 2014 
Why I Like These Two Health Care Stocks Aug 29 2014 
Global for Resilience – Columbia Management Selling Update Aug 29 2013 
4stars, lots of buys Dec 21 2011 
New Guru Added: Ray Dalio of Bridgewater Associates Dec 02 2011 
DENTSPLY International Inc. Reports Operating Results (10-K) Feb 18 2011 
Align Technologies Takes One in the Teeth Apr 06 2010 
Tom Gayner Top Buys: ITC Holdings Corp., Patterson Companies Inc., Schlumberger Ltd., Walgreen Compa Nov 09 2009 
Richard Aster Jr Buys Zebra Technologies Corp., Bunge Ltd., Liz Claiborne Inc., Sells Time Warner In Nov 03 2006 

More From Other Websites
DENTSPLY International Inc. to Present at the Goldman Sachs 36th Annual Global Healthcare Conference Jun 08 2015
DENTSPLY International Inc. to Present at the Jefferies 2015 Global Healthcare Conference Jun 01 2015
DENTSPLY-German Works Council Plan Lab Restructuring - Analyst Blog May 27 2015
DENTSPLY INTERNATIONAL INC /DE/ Files SEC form 8-K, Costs Associated with Exit or Disposal... May 26 2015
DENTSPLY International Inc. to Present at the Stifel 2015 Dental & Veterinary Conference May 26 2015
DENTSPLY International Announces Lab Restructuring May 26 2015
DENTSPLY INTERNATIONAL INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers,... May 21 2015
DENTSPLY International Inc. Declares Cash Dividend May 20 2015
DENTSPLY International Announces Retirement of Board Member Leslie Jones May 20 2015
Will Healthcare and Biotech Propel Stocks Higher? May 19 2015
DENTSPLY INTERNATIONAL INC /DE/ Financials May 15 2015
DENTSPLY International Inc. to Present at the Bank of America Merrill Lynch Healthcare Conference May 12 2015
10-Q for DENTSPLY International, Inc. May 08 2015
Company News for May 07, 2015 - Corporate Summary May 07 2015
DENTSPLY Q1 Earnings Beat Estimates by a Penny; Sales Lag - Analyst Blog May 06 2015
Dentsply Intl (XRAY) Earnings Report: Q1 2015 Conference Call Transcript May 06 2015
DENTSPLY International Inc Earnings Call scheduled for 8:30 am ET today May 06 2015
DENTSPLY International Reports First Quarter 2015 Results May 06 2015
DENTSPLY INTERNATIONAL INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition,... May 06 2015
Dentsply tops 1Q profit forecasts May 06 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK